JP2021119164A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021119164A5 JP2021119164A5 JP2021074407A JP2021074407A JP2021119164A5 JP 2021119164 A5 JP2021119164 A5 JP 2021119164A5 JP 2021074407 A JP2021074407 A JP 2021074407A JP 2021074407 A JP2021074407 A JP 2021074407A JP 2021119164 A5 JP2021119164 A5 JP 2021119164A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- buffer solution
- compound
- mannitol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 32
- 239000007853 buffer solution Substances 0.000 claims 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims 9
- 150000001875 compounds Chemical class 0.000 claims 5
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical group OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims 4
- 229930195725 Mannitol Natural products 0.000 claims 4
- 239000000594 mannitol Substances 0.000 claims 4
- 235000010355 mannitol Nutrition 0.000 claims 4
- 239000000546 pharmaceutical excipient Substances 0.000 claims 3
- 229940125782 compound 2 Drugs 0.000 claims 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims 2
- 239000001509 sodium citrate Substances 0.000 claims 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims 1
- LJHFUFVRZNYVMK-CYBMUJFWSA-N [3-[4-(aminomethyl)-6-(trifluoromethyl)pyridin-2-yl]oxyphenyl]-[(3R)-3-hydroxypyrrolidin-1-yl]methanone Chemical compound NCC1=CC(=NC(=C1)C(F)(F)F)OC=1C=C(C=CC=1)C(=O)N1C[C@@H](CC1)O LJHFUFVRZNYVMK-CYBMUJFWSA-N 0.000 claims 1
- 239000008351 acetate buffer Substances 0.000 claims 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims 1
- 229910052782 aluminium Inorganic materials 0.000 claims 1
- 239000000872 buffer Substances 0.000 claims 1
- 239000011888 foil Substances 0.000 claims 1
- 239000004310 lactic acid Substances 0.000 claims 1
- 235000014655 lactic acid Nutrition 0.000 claims 1
- 239000000243 solution Substances 0.000 claims 1
- 239000001384 succinic acid Substances 0.000 claims 1
- 239000011975 tartaric acid Substances 0.000 claims 1
- 235000002906 tartaric acid Nutrition 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562183403P | 2015-06-23 | 2015-06-23 | |
| US62/183,403 | 2015-06-23 | ||
| US201562268666P | 2015-12-17 | 2015-12-17 | |
| US62/268,666 | 2015-12-17 | ||
| JP2017566743A JP6876631B2 (ja) | 2015-06-23 | 2016-06-22 | 白金化合物、組成物及びその使用 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017566743A Division JP6876631B2 (ja) | 2015-06-23 | 2016-06-22 | 白金化合物、組成物及びその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021119164A JP2021119164A (ja) | 2021-08-12 |
| JP2021119164A5 true JP2021119164A5 (enExample) | 2021-09-24 |
| JP7223053B2 JP7223053B2 (ja) | 2023-02-15 |
Family
ID=57586683
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017566743A Expired - Fee Related JP6876631B2 (ja) | 2015-06-23 | 2016-06-22 | 白金化合物、組成物及びその使用 |
| JP2021074407A Active JP7223053B2 (ja) | 2015-06-23 | 2021-04-26 | 白金化合物、組成物及びその使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017566743A Expired - Fee Related JP6876631B2 (ja) | 2015-06-23 | 2016-06-22 | 白金化合物、組成物及びその使用 |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US10342801B2 (enExample) |
| EP (1) | EP3313392B1 (enExample) |
| JP (2) | JP6876631B2 (enExample) |
| WO (1) | WO2016209918A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX377528B (es) | 2015-12-09 | 2025-03-10 | Univ Wien Med | Compuestos de platino funcionalizados con monomaleimida para la terapia del cáncer. |
| RU2019138773A (ru) | 2017-05-05 | 2021-06-08 | Интезайн Текнолоджис, Инк. | Производство транс-[тетрахлорбис(1h-индазол)рутената(iii)] и его композиций |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2043635A2 (en) * | 2006-06-29 | 2009-04-08 | Astex Therapeutics Limited | Pharmaceutical combinations |
| WO2013033430A1 (en) * | 2011-09-02 | 2013-03-07 | Wake Forest School Of Medicine | Targeted delivery and prodrug designs for platinum-acridine anti-cancer compounds and methods thereof |
| WO2014100417A1 (en) * | 2012-12-19 | 2014-06-26 | Blend Therapeutics, Inc. | Compounds, compositions, and methods for the treatment of cancers |
| US10011622B2 (en) * | 2013-12-31 | 2018-07-03 | Placon Therapeutics, Inc. | Compounds, compositions, and methods for the treatment of cancers |
| CA2953350C (en) * | 2014-06-23 | 2019-11-26 | Placon Therapeutics, Inc. | Platinum compounds, compositions, and uses thereof |
-
2016
- 2016-06-22 WO PCT/US2016/038699 patent/WO2016209918A1/en not_active Ceased
- 2016-06-22 JP JP2017566743A patent/JP6876631B2/ja not_active Expired - Fee Related
- 2016-06-22 US US15/737,064 patent/US10342801B2/en active Active
- 2016-06-22 EP EP16815194.2A patent/EP3313392B1/en not_active Not-in-force
-
2019
- 2019-05-16 US US16/413,719 patent/US20190350940A1/en not_active Abandoned
-
2021
- 2021-04-26 JP JP2021074407A patent/JP7223053B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020007356A5 (enExample) | ||
| RU2012108632A (ru) | Сублингвальные и буккальные пленочные композиции | |
| JP2018021007A5 (enExample) | ||
| JP2019504086A5 (enExample) | ||
| JP2021119164A5 (enExample) | ||
| FI3817751T3 (fi) | Vedettömän natriumtiosulfaatin formulaatioita | |
| RU2006118689A (ru) | Содержащий фармацевтический агент состав с покрытием | |
| RU2011122629A (ru) | Водная композиция, содержащая фолликулостимулирующий гормон | |
| ES2897981T3 (es) | Composición de dos componentes que comprende ácido acetilsalicílico | |
| WO2018226987A1 (en) | Compositions for treating fungal and bacterial biofilms and methods of using the same | |
| RU2005133665A (ru) | Применение производных 10-гидрокси-10,11-дигидрокарбамазепина для лечения аффективных расстройств | |
| JP2020510619A5 (enExample) | ||
| JPWO2018221487A1 (ja) | エリブリンまたはその薬剤学的に許容される塩を含む注射剤 | |
| ES2946237T3 (es) | Sistemas de dos componentes que comprenden ácido acetilsalicílico y una sal de carbonato | |
| JPH0692849A (ja) | フラン誘導体を含有する医薬組成物 | |
| CA2466770A1 (en) | Liquid pharmaceutical formulations of acetaminophen and an alkali metal 1-lactate salt | |
| JP2019502751A5 (enExample) | ||
| CA2514124A1 (en) | Absorption enhancing agents | |
| JP7525701B2 (ja) | カルボプラチンの非経口剤形 | |
| JP2005535644A5 (enExample) | ||
| US10363254B2 (en) | Methods for treating cryptosporidiosis using triazolopyridazines | |
| CN1636553A (zh) | 防挥发型固体制剂及其制造方法 | |
| CN1210028C (zh) | 水性液体制剂 | |
| RU2011134414A (ru) | Комбинация фульвовой кислоты для лечения различных состояний и болезней | |
| JP2007534731A5 (enExample) |